Last update:

Oncology & Cancer news

Oncology & Cancer

Research finds the protein VISTA directly blocks T cells from functioning in immunotherapy

A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.

Oncology & Cancer

Gut bacteria enhance cancer immunotherapy in mouse study

Roughly one in five cancer patients benefit from immunotherapy—a treatment that harnesses the immune system to fight cancer. Such an approach to beating cancer has seen significant success in lung cancer and melanoma, among ...

Oncology & Cancer

Study uncovers new target for breast cancer medications

The mammary gland is a complex tissue comprising a variety of cell types. Its proper functioning is crucial for the health of the breast. Among the numerous factors regulating cell homeostasis in the mammary gland, transcription ...

Oncology & Cancer

Video: Who should be screened for skin cancer?

Skin cancer is the most common cancer in the U.S. Each year, more than 6 million adults are treated for skin cancer, according to the Centers for Disease Control and Prevention.

Oncology & Cancer

Unraveling the link between the microbiome and esophageal cancer

Esophageal cancer (EC) is an aggressive malignancy with a poor prognosis, with its development and progression potentially influenced by changes in the esophageal microbiome. Recent studies have revealed that specific microbiome ...

Oncology & Cancer

Strengthening CAR-T therapy to work against solid tumors

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance ...

Medical research

Researchers discover new target for potential leukemia therapy

A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival. The study provides both mechanistic and preclinical ...

Oncology & Cancer

Early onset bowel cancer cases increasing in New Zealand

There's a fresh call for a lowering of the bowel cancer screening age in Aotearoa New Zealand, in the wake of new University of Otago, Christchurch research showing an alarming rise in colorectal cancer rates in younger New ...

Oncology & Cancer

How TP53 gene loss drives gastric cancer evolution

Gastric cancer (GC) ranks as the fifth-most common and fourth-deadliest cancer worldwide, presenting significant health challenges, particularly in China, where it is most prevalent and accounts for nearly half of newly diagnosed ...

Medications

How the drug abemaciclib treats breast cancer

The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.